Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort

Recruiting now

Conditions studied: Post-Acute COVID-19 Syndrome

In brief

The study aims to identify clinical profiles of long-COVID patients and correlate them with immunological and molecular data in order to identify prognostic biomarkers and potential therapeutic targets.

Key facts

Study ID

NCT07356570

Run by

Hospices Civils de Lyon

People needed

150

Starts

2025-06-13

Expected to finish

2026-06-01

Last updated by the study team

2026-01-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented SARS-CoV-2 infection
• Persistent or complex post-COVID symptoms lasting more than 4 weeks or more than 3 months
• Patient referred to the EPSILON pathway or to the post-COVID rehabilitation unit
• Age ≥ 18 years
• Non-institutionalized
• Expected survival greater than 6 months

You may not qualify if…

• Refusal to participate or to share data
• Uncontrolled comorbidities
• Pregnant or breastfeeding women
• Persons under legal protection or deprived of liberty
• Not affiliated with the French national health insurance system

Where it is running

• Service Pneumologie aigue spécialisée et cancérologie thoracique — Pierre-Bénite, France (enrolling)
• Hôpital Henry Gabrielle-HCL — Saint-Genis-Laval, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.